Pankaj Malhotra to Multiple Myeloma
This is a "connection" page, showing publications Pankaj Malhotra has written about Multiple Myeloma.
Connection Strength
1.423
-
Real world experience with "generic" pomalidomide in relapsed refractory multiple myeloma. Leuk Lymphoma. 2019 04; 60(4):1102-1104.
Score: 0.373
-
AYA-Myeloma: Real-World, Single-Center Experience Over Last 5 Years. J Adolesc Young Adult Oncol. 2018 02; 7(1):120-124.
Score: 0.345
-
Plasma cells with hairy projections and Auer rod-like inclusions in a patient with multiple myeloma. BMJ Case Rep. 2017 Aug 03; 2017.
Score: 0.344
-
Impact of frailty, melphalan pharmacokinetics, and pharmacogenetics on outcomes post autologous hematopoietic cell transplantation for multiple myeloma. Bone Marrow Transplant. 2019 12; 54(12):2088-2095.
Score: 0.099
-
Recent advances in the management of multiple myeloma: clinical impact based on resource-stratification. Consensus statement of the Asian Myeloma Network at the 16th international myeloma workshop. Leuk Lymphoma. 2018 10; 59(10):2305-2317.
Score: 0.089
-
Multiple myeloma or lymphoma? The increasing role of flow cytometry and serum-free light chain assay. Indian J Pathol Microbiol. 2018 Jan-Mar; 61(1):149-150.
Score: 0.088
-
Evaluation of Bortezomib-Induced Neuropathy Using Total Neuropathy Score (Reduced and Clinical Versions) and NCI CTCAE v4.0 in Newly Diagnosed Patients With Multiple Myeloma Receiving Bortezomib-Based Induction. Clin Lymphoma Myeloma Leuk. 2017 08; 17(8):513-519.e1.
Score: 0.085